Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Recht

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Human Molecular Genetics|February 2, 2013
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia AJérôme Lane, Paul J McLaren, Lucy Dorrell, et al.
Pageof 14